Answers are grounded in this paper and cite their sources.
Together, our findings highlight the function of SETD2 during pancreatic carcinogenesis, which would advance our understanding of epigenetic dysregulation in PDAC. Moreover, it may also pave the way for development of targeted, patients-tailored therapies for PDAC patients with SETD2 deficiency.
No takes yet. Share an insight, caveat, or question.
Niu et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: